专利号:US-6642377-B1 优先权日:1999-07-30 标 题 :Process for the preparation of basic antibiotic-inorganic acid addition salts and intermediate oxalates 发明人:KAYANO AKIO; CHIBA HIROYUKI; NAKAMURA TAIJU; SAKURAI SHIN; ISHIZUKA HIROYUKI; SAITO HIROYUKI; KOMATSU YUUKI; SASHO MANABU; SATO NOBUAKI; NEGI SHIGETO 权利人:EISAI CO LTD 摘要:A production process which comprises subjecting a basic antibiotic.oxalate (II) to salt-exchange with an alkali earth metal salt (III) of an inorganic acid:wherein the ring A means the basic antibiotic; R<10 >means a protected functional group used in organic synthesis; Ak-E means the alkali earth metal; and B means the inorganic acid, respectively.
专利号:CN-114540454-B 优先权日:2022-03-09 标 题:A method for enzymatic synthesis of cefcapine hydrochloride and its synthetic intermediates
专利号:CN-106220648-B 优先权日:2016-07-30 标题:A kind of synthesis of tertbutyloxycarbonyl Cefcapene diisopropylamine and purification process
专利号:CN-106220648-A 优先权日:2016-07-30 标题:A kind of synthesis and purification method of tert-butoxycarbonyl cefcapene acid diisopropylamine salt
专利号:CN-101747344-B 优先权日:2009-12-22 标 题 :Synthesis Method of cefcapene pivoxil hydrochloride
专利号:CN-101747344-A 优先权日:2009-12-22 标题 :Synthesis Method of cefcapene pivoxil hydrochloride
1: Iwata E, Tachibana A, Kusumoto J, Takata N, Hasegawa T, Akashi M. Does prophylactic antibiotic administration for tooth extraction affect PT-INR in patients taking warfarin? BMC Oral Health. 2020 Nov 19;20(1):331. doi: 10.1186/s12903-020-01326-w. 2: Sakaida T, Tanimoto I, Matsubara A, Nakamura M, Morita A. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19? J Dermatol Sci. 2020 Jul;99(1):62-64. doi: 10.1016/j.jdermsci.2020.05.002. Epub 2020 May 16. 3: Okamoto K, Asano S, Yamamoto T, Toyono T, Yamaguchi R, Okada Y, Okugawa S, Suzuki H, Moriya K, Aihara M. Poor penetration of cefcapene into aqueous humor after oral administration of cefcapene pivoxil to patients undergoing cataract surgery. J Infect Chemother. 2020 Feb;26(2):312-315. doi: 10.1016/j.jiac.2019.08.004. Epub 2019 Aug 31. 26(1):86-91. doi: 10.1016/j.jiac.2019.07.013. Epub 2019 Aug 7. 58(19):2891-2894. doi: 10.2169/internalmedicine.2339-18. Epub 2019 Jun 27.
合成参考文献
摘要:Iyakuhin Kenkyu. Study of Medical Supplies., 24(186), 1993 参考文献:10.1128/aac.36.4.757 摘要:Totsuka K, Shimizu K, Konishi M, Yamamoto S. Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans. Antimicrob Agents Chemother. 1992 Apr;36(4):757–61. 参考文献:10.1128/aac.36.4.762|10.1128/aac.36.7.1587 摘要:Nakashima M, Uematsu T, Oguma T, Yoshida T, Mizojiri K, Matsuno S, Yamamoto S. Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores. Antimicrob Agents Chemother. 1992 Apr;36(4):762–8.